Clinical Trials Directory

Trials / Completed

CompletedNCT02824744

Comparison Between 2l vs 3l in HFNC During the Initial Management of Severe Bronchiolitis in Infants

Comparison Between 2l/Min/kg vs 3l/Min/kg in High Flow Nasal Cannula (HFNC) During the Initial Management of Severe Bronchiolitis in Infants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
300 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
0 Hours – 6 Months
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate prospectively the clinical benefits of 2 different flow with High flow nasal canula (HFNC: 2l/kg/min) versus (HFNC: 2l/kg/min) in the initial management of bronchiolitis in infants. Design: Prospective, controlled, randomized, multi-center. Design: Infants less than 6 month admitted in pediatric intensive care unit for respiratory distress (mWCAS \>3) secondary to bronchiolitis but not requiring mechanical ventilation will be randomized in two groups:HFNC "2l/min/kg" or HFNC "3l/min/kg" during 24 hours. Conditions of measurements: Primary endpoint: Proportion of failure in both arms during the first 24 hours. Failure criteria: A raise of the Clinical score for respiratory distress (mWCAS) (1 point) or respiratory rate (10/min /H0 and above 60/min) or discomfort (EDIN) (1point /H0 and above 4) or apnea. Secondary outcomes: Assessment at H1, H12, H24 of mWCAS, respiratory and heart rate, EDIN score, skin lesions, FiO2 required to achieve an oxygen saturation between 94 and 97%, transcutaneous PCO2 (correlated to an initial gas analysis), Report SpO2 / FiO2 Statistic: Intention to treat Analysis. Expected number of patients: 135 per arm: 270 children.

Conditions

Interventions

TypeNameDescription
DEVICEtreatment by 2l/min/kg in High Flow Nasal cannula (HFNC)
DEVICEtreatment by 3l/min/kg in High Flow Nasal cannula (HFNC)

Timeline

Start date
2016-11-02
Primary completion
2017-03-17
Completion
2018-03-01
First posted
2016-07-07
Last updated
2024-05-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02824744. Inclusion in this directory is not an endorsement.